This startup is developing a new Artificial Heart Valve, with a unique anatomical design made up of three fully-opening leaflets that meets the long-sought-after triple objectives in the medical industry: reducing costs (lower manufacturing expenses), non-thrombogenic (no need for anticoagulants), and no structural deterioration (infinite shelf life).

This valve improves both results and patient experience compared to those existing in the market, since it eliminates the need for patients to have new procedures or take additional medication.